Yahoo · Oct 8, 2026
bioMérieux (ENXTPA:BIM) Launches SPINCHIP, Is The Stock Fully Priced?
bioMérieux (ENXTPA:BIM) has put its new SPINCHIP point of care platform in front of emergency physicians in Paris, pairing the device with a CE marked high sensitivity cardiac troponin I test. Recent trading suggests investors are reacting positively to news like SPINCHIP, with the share price up 11.30% over 30 days and 12.70% over 90 days. However, the stock is still facing a year-to-date share price return that is down 26.26% and a 1-year total shareholder return that is down 27.11%,...


